NCT06434025: IV Iron and SGLT2 Inhibitor on Ventricular Function and Myocardial Iron Content in Heart Failure With Iron Deficiency
- State
- Not started
- Phase
- Phase 3
- People
- 99 planned
- Started
- 24 May 2024
- Primary completion
- 24 May 2026
- Arms
- ferric carboxymaltose + SGLT2 inhibitor
- Results
- None posted
- 30 May 2024: Trial registered